GlassScriptPhysician profile
Brian M Woo
NPI 1558579144
$5,602.09
in general payments reported to CMS, 2019-2025
13 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,460 · 2020: $230 · 2021: $516 · 2022: $572 · 2023: $578 · 2024: $845 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,208.15 | 2019-2024 | Inspire |
| Depuy Synthes Sales INC. | $788.27 | 2020-2025 | Trumatch, Matrixmidface, Na |
| Kls-Martin L.P. | $773.05 | 2019-2025 | |
| Axogen | $564.82 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Zimmer Biomet Holdings, INC. | $432.63 | 2019 | |
| Geistlich Pharma, North America, INC. | $302.21 | 2023-2024 | Geistlich Bio-Gide, Bio-Materials |
| Stryker Corporation | $168.53 | 2019-2024 | Na |
| Southern Implants North America INC | $119.08 | 2021 | |
| Olympus America INC. | $92.53 | 2019 | |
| Ethicon US, LLC | $42.18 | 2022 | |
| Straumann USA LLC | $40.97 | 2024 | |
| Nobel Biocare USA | $34.84 | 2023 | Nobelactive |
| Implant Direct Sybron International LLC | $34.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Woo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.